Vanguard Personalized Indexing Management LLC boosted its holdings in Olaplex Holdings, Inc. (NASDAQ:OLPX – Free Report) by 38.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 25,819 shares of the company’s stock after buying an additional 7,235 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Olaplex were worth $40,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. lifted its position in Olaplex by 8.4% in the 1st quarter. Vanguard Group Inc. now owns 11,935,003 shares of the company’s stock valued at $22,915,000 after acquiring an additional 929,693 shares in the last quarter. Bank of New York Mellon Corp lifted its position in Olaplex by 29.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 942,288 shares of the company’s stock worth $1,451,000 after buying an additional 212,129 shares in the last quarter. Wedmont Private Capital boosted its stake in shares of Olaplex by 96.6% during the 1st quarter. Wedmont Private Capital now owns 36,794 shares of the company’s stock worth $71,000 after buying an additional 18,081 shares during the last quarter. Quadrature Capital Ltd grew its holdings in shares of Olaplex by 50.4% in the 1st quarter. Quadrature Capital Ltd now owns 88,206 shares of the company’s stock valued at $170,000 after acquiring an additional 29,545 shares in the last quarter. Finally, Syon Capital LLC bought a new position in Olaplex in the fourth quarter valued at approximately $115,000. 87.37% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at Olaplex
In related news, Director John P. Bilbrey purchased 183,493 shares of the firm’s stock in a transaction on Monday, August 19th. The stock was purchased at an average cost of $2.05 per share, with a total value of $376,160.65. Following the completion of the purchase, the director now owns 241,593 shares in the company, valued at approximately $495,265.65. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 4.20% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Analysis on Olaplex
Olaplex Price Performance
Olaplex stock opened at $2.33 on Wednesday. The company has a market capitalization of $1.54 billion, a PE ratio of 33.29 and a beta of 2.42. The company has a current ratio of 9.27, a quick ratio of 7.85 and a debt-to-equity ratio of 0.75. The stock has a 50-day moving average price of $2.16 and a two-hundred day moving average price of $1.81. Olaplex Holdings, Inc. has a 12 month low of $1.19 and a 12 month high of $2.98.
Olaplex (NASDAQ:OLPX – Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $0.03 EPS for the quarter, hitting the consensus estimate of $0.03. Olaplex had a return on equity of 11.16% and a net margin of 10.95%. The firm had revenue of $103.90 million for the quarter, compared to the consensus estimate of $103.65 million. During the same period in the previous year, the business earned $0.03 EPS. The business’s quarterly revenue was down 4.9% compared to the same quarter last year. Analysts expect that Olaplex Holdings, Inc. will post 0.14 EPS for the current year.
Olaplex Profile
Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.
Further Reading
- Five stocks we like better than Olaplex
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Canada Bond Market Holiday: How to Invest and Trade
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Upcoming IPO Stock Lockup Period, Explained
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.